The Burden of COVID-19 Infection in a Rural Tamil Nadu Community. Preprint GHDx Entry last modified on: Mar 14, 2022
Anti-SARS-CoV-2 IgG seroprevalence study among blood donors in the Republic of Srpska: a 30-day survey Studija seroprevalencije anti-SARS-CoV-2 IgG kod davalaca krvi u Republici Srpskoj: 30-dnevno ispitivanje GHDx Entry last modified on: Mar 14, 2022
Prevalence of SARS-CoV-2 in six districts in Zambia in July, 2020: a cross-sectional cluster sample survey GHDx Entry last modified on: Feb 10, 2022
SARS-CoV-2 seroprevalence in Germany - a population based sequential study in five regions. Preprint GHDx Entry last modified on: Mar 14, 2022
Dramatic Rise of Seroprevalence Rates of SARS-CoV-2 Antibodies among Healthy Blood Donors: The evolution of a Pandemic. Preprint GHDx Entry last modified on: Oct 6, 2022
SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic GHDx Entry last modified on: Dec 11, 2023
Sero-prevalence of SARS-CoV-2 Antibody Among Adults in the General Population in Diredawa, Ethiopia. Preprint GHDx Entry last modified on: Sep 13, 2022
Declining prevalence of antibody positivity to SARS-CoV-2: a community study of 365,000 adults. Preprint GHDx Entry last modified on: May 12, 2022
SARS-CoV-2 antibody prevalence and symptoms in a local Austrian population. Preprint GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 seroprevalence and characteristics of post-infection immunity in a general population cohort study in Catalonia, Spain. Preprint GHDx Entry last modified on: May 12, 2022
A global survey of potential acceptance of a COVID-19 vaccine GHDx Entry last modified on: Jun 17, 2021
Variation in SARS-CoV-2 seroprevalence in school-children across districts, schools and classes. Preprint GHDx Entry last modified on: Mar 14, 2022
Rapid increase of SARS-CoV-2 seroprevalence during the 2020 pandemic year in the population of the city of Tirana, Albania. Preprint GHDx Entry last modified on: May 12, 2022
Seroprevalence of SARS-CoV-2 in the West Bank region of Palestine: a cross-sectional seroepidemiological study GHDx Entry last modified on: Mar 14, 2022
Increase in SARS-CoV-2 seroprevalence in healthy blood donors after the second wave of COVID-19 pandemic in South-Eastern Italy: evidence for asymptomatic young individuals as potential virus spreaders. Preprint GHDx Entry last modified on: Mar 14, 2022
Fernando de Noronha: how an island controlled the community transmission of COVID-19 in Brazil. Preprint GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 antibodies in an entirely PCR-sampled and quarantined community after a COVID-19 outbreak - the CoNAN study. Preprint GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 IgM and IgG antibodies in an asymptomatic population in Sergipe, Brazil GHDx Entry last modified on: Jun 17, 2021
Population-Based Random Survey for detection of COVID-19 Infection and Seroprevalence in Benghazi- Libya May/2020 GHDx Entry last modified on: Oct 3, 2022
The seroprevalence of SARS-CoV-2 IgG antibodies among asymptomatic blood donors in Saudi Arabia GHDx Entry last modified on: Jun 17, 2021
Anti-SARS-CoV-2 IgG antibodies in adolescent students and their teachers in Saxony, Germany (SchoolCoviDD19): very low seropraevalence and transmission rates. Preprint GHDx Entry last modified on: Mar 14, 2022
Positive Rate of Serology and RT-PCR for COVID-19 between Community Residents and Healthcare Workers in Wuhan, China GHDx Entry last modified on: Mar 14, 2022
Strategies for Infection Control and Prevalence of Anti-SARS-CoV-2 IgG Antibodies in 4,554 Employees of a University Hospital in Munich, Germany. Preprint GHDx Entry last modified on: Mar 14, 2022
Sero-prevalence of anti-SARS-CoV-2 Antibodies in Addis Ababa, Ethiopia. Preprint GHDx Entry last modified on: Mar 14, 2022
A COVID-19 Hotspot Area: Activities and Epidemiological Findings GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020 GHDx Entry last modified on: Mar 14, 2022
Changes in PTSD, depression, and generalized anxiety before and during the COVID-19 pandemic in the Republic of Ireland. Preprint. GHDx Entry last modified on: Nov 3, 2022
COVID-19 at a metropolitan region: public polices and social vulnerability within an iniquity context. Preprint COVID-19 em uma Região Metropolitana: vulnerabilidade social e políticas públicas em contextos de desigualdades GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of COVID-19 virus infection in Guilan province, Iran. Preprint GHDx Entry last modified on: Mar 14, 2022
Mood Symptoms Predict COVID-19 Pandemic Distress but not Vice Versa: An 18-Month Longitudinal Study. Preprint. GHDx Entry last modified on: Mar 14, 2022
Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies: Results from a population-based study in Bonn, Germany. Preprint GHDx Entry last modified on: Mar 14, 2022
Comparing mental health during COVID-19 lockdown and six months later in Austria: A longitudinal study. Preprint. GHDx Entry last modified on: Sep 9, 2022
Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020 GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of Specific Antibodies against SARS-CoV-2 from Hotspot Communities in the Dominican Republic GHDx Entry last modified on: Mar 14, 2022
Prevalence of SARS-CoV-2 Antibodies from a one-year National Serosurveillance of Kenyan Blood Transfusion Donors. Preprint GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 Seroprevalence During the First and Second Pandemic Waves in Canada. Preprint. GHDx Entry last modified on: May 12, 2022
SARS-CoV-2 Seroprevalence Survey Estimates Are Affected by Anti-Nucleocapsid Antibody Decline GHDx Entry last modified on: May 12, 2022
SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states, Germany, March to June 2020 GHDx Entry last modified on: Mar 14, 2022
Detection of neutralising antibodies to SARS coronavirus 2 to determine population exposure in Scottish blood donors between March and May 2020. Preprint GHDx Entry last modified on: May 12, 2022
Perceived threat and acute anxiety predict increased everyday altruism during the COVID-19 pandemic GHDx Entry last modified on: Oct 6, 2022
Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020 GHDx Entry last modified on: May 12, 2022
Spain Prevalence of Depression, Before and After the Covid-19 Pandemic 2020 GHDx Entry last modified on: Oct 10, 2022
Infection fatality rate of SARS-CoV-2 infection in a German community with a super-spreading event. Preprint GHDx Entry last modified on: Mar 14, 2022
Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, March and April 2020 GHDx Entry last modified on: Mar 14, 2022
Herd immunity of sars-cov-2 among the population of Kalinigrad region amid the COVID-19 epidemic Популяционный иммунитет к SARS-COV-2 населения Калиниградской области в эпидемический сезон COVID-19 GHDx Entry last modified on: Mar 14, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Among Adults in a Tropical City of the Caribbean Area, Colombia: Are We Much Closer to Herd Immunity Than Developed Countries? GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study GHDx Entry last modified on: Mar 14, 2022